Urinari-X
On sale on the US market (according to the DSLD)
LifeSeasons Therapeutics, food supplement from the US market
Urinari-X (LifeSeasons Therapeutics), a food supplement au code-barres 853760002124, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- LifeSeasons Therapeutics
- Barcode
- 853760002124
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Rice Bran, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| D-Mannose | Carbohydrate | 600 mg |
| Cranberry | Plant | 450 mg |
| Coconut Oil, Powder | Fat | 250 mg |
| Caprylic Acid | Fatty acid | 138 mg |
| Grapefruit Seed Extract (Citrus paradisi) | Plant | 100 mg |
| Olive Leaf Extract | Plant | 100 mg |
| Oleuropein | Other substance | 15 mg |
| Oregano Leaf Extract | Plant | 100 mg |
| Uva-ursi (Arctostaphylos uva-ursi) | Plant | 75 mg |
| Marshmallow (Althaea officinalis) | Plant | 75 mg |
| Red Raspberry (Rubus idaeus) | Plant | 50 mg |
| Bilberry | Plant | 20 mg |
| Blueberry | Plant | 5 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Urinari-X
Entered into DSLD on 23 June 2021. Withdrawn from the US market on 13 March 2023 (according to the DSLD).- Active ingredient removed : Caprylic Acid (138 mg)
- Active ingredient removed : Oleuropein (15 mg)
- Same quantity, different name: Coconut Oil in this version; Coconut Oil, Powder on the displayed label (250 mg)
Official label: Urinari-X
Entered into DSLD on 23 April 2020. Withdrawn from the US market on 19 March 2021 (according to the DSLD).- Active ingredient added : Coconut Oil (500 mg)
- Active ingredient removed : Caprylic Acid (138 mg)
- Active ingredient removed : Coconut Oil, Powder (250 mg)
- Active ingredient removed : Oleuropein (15 mg)
Official label: Urinari-X Urinary/Yeast Support
Entered into DSLD on 25 July 2014. Withdrawn from the US market on 7 October 2019 (according to the DSLD).- Active ingredient added : Grape seed extract (100 mg)
- Active ingredient added : Oregano (100 mg)
- Active ingredient added : Potassium Caprylate (500 mg)
- Active ingredient removed : Caprylic Acid (138 mg)
- Active ingredient removed : Coconut Oil, Powder (250 mg)
- Active ingredient removed : Grapefruit Seed Extract (100 mg)
- Active ingredient removed : Oleuropein (15 mg)
- Active ingredient removed : Oregano Leaf Extract (100 mg)
- Same quantity, different name: Cranberry 90 mx in this version; Cranberry on the displayed label (450 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Uva-ursi
Read the warning, when it applies and the studies cited
Bearberry - Arctostaphylos Uva-Ursi
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Applies to products providing 60 milligrams or more of dried leaves and/or products providing 20 milligrams or more of Arbutin, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine (EMA 2018; Duke 2002; Newall 1996).
Sources cited by Health Canada (2)
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A guide for health-care professionals. London (GB): The Pharmaceutical Press; 1996.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2018; Brinker 2010; ESCOP 2003; WHO 2002; Blumenthal 2000; Mills and Bone 2000; Bradley 1992).
Sources cited by Health Canada (8)
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium Volume 1: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion Volume 1 of the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- ESCOP 2003: European Scientific Cooperative of Phytotherapy. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition completely revised and expanded. Exeter (GB): European Scientific Cooperative on Phytotheraphy; 2003.
- Mills S, Bone K. Principles and Practice of Phytotherapy, Modern Herbal Medicine. Edinburg (GB): Churchill LYes Soivingston; 2000.
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3. Geneva (CH): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 3. Genève (CH): Organisation mondiale de la santé; 2002.
- Marshmallow
Read the warning, when it applies and the studies cited
Marshmallow - ALTHAEA OFFICINALIS - Root
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Health Canada monograph dated 19 December 2025
MARSHMALLOW - ALTHAEA OFFICINALIS - LEAF
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : LifeSeasons Therapeutics
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Urinari-X (LifeSeasons Therapeutics): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/853760002124-urinari-x-lifeseasons-therapeutics, updated 25 July 2024.